Research Field

With cell and gene therapies being all the rage, we take a peek at some of the advanced therapies coming down the pipe.

Tomorrow’s cures for retinopathies will likely include advanced gene and cell therapies delivered by precision surgery.

Differences in bacterial diversity in the gut could be used to identify patients with Barrett’s esophagus and esophageal cancer.

China drafts new gene-editing regulations – but concerns over their enforcement remain.

A novel protein platform helps neutralize powerful MRSA toxins.

We should be thrilled with the success of the approved CD-19 CAR-T therapies. But the field is still young, and we are only scratching the surface.

Harvard Medical School’s Richard Sherwood digs into the potential and pitfalls of gene editing technology.

How DNA origami nanostructures could find their way into the treatment of acute kidney injury.

Two chemical components; opposite effects. How medical marijuana impacts glaucoma for better – and for worse.

We sat down with David Eidelberg shortly after the publication of his group’s most recent paper in Science Translational Medicine.